IP Verse

Small Liposomes For Delivery Of Immunogen-Encoding Rna

PatentPatent Analysis

EP2611467

GLAXOSMITHKLINE BIOLOGICALS
Application Number
EP11755497A
Filing Date
Aug 31, 2011
Status
Revoked
Jan 24, 2025
Grant Date
Jul 20, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3480209B1
EP3564378B1
EP4066819B1

Bibliography

The patent EP2611467B1 was granted to Glaxosmithkline Biologicals on Jul 20, 2022 following the initial filing on Aug 31, 2011 under the application number EP11755497A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

JG OPPOSITIONSApr 20, 2023ADMISSIBLE
MARGARET DIXONApr 20, 2023ADMISSIBLE
HOPFNERApr 18, 2023ADMISSIBLE
WEICKMANN & WEICKMANN PARTMBBApr 18, 2023ADMISSIBLE
SANOFIApr 17, 2023ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents